权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Metabolic engineering of cannabis biopathways

大麻生物途径的代谢工程

基本信息

批准号：
485742-2015
负责人：
Johnson, Douglas
金额：
$ 1.82万
依托单位：
University of Ottawa
依托单位国家：
加拿大
项目类别：
Engage Grants Program
财政年份：
2015
资助国家：
加拿大
起止时间：
2015-01-01 至 2016-12-31
项目状态：
已结题

来源：
https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=585181
关键词：
Metabolic engineering cannabis biopathways

项目摘要

Innovation generates new products and the sale of new products drives growth. The medical marijuana plant, Cannabis sativa, produces a range of compounds with proven and potential value as pharmaceuticals. In some instances, these compounds are produced at low levels but increasing their level within the plant can increase the commercial viability of the products and reduce costs of purification and production. This application will provide the means to modify metabolism by directing the plant to channel more energy and metabolites into the production of a range of potential pharmaceuticals thus increasing Tweeds products, sales and growth.

创新产生新产品，新产品的销售带动增长。医用大麻植物大麻

项目成果

期刊论文数量（0）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

数据更新时间：{{ journalArticles.updateTime }}

DOI：
{{ item.doi }}
发表时间：
{{ item.publish_year }}
期刊：
{{ item.journal_name }}
影响因子：
{{ item.factor }}
作者：
{{ item.authors }}
通讯作者：
{{ item.author }}

数据更新时间：{{ journalArticles.updateTime }}

作者：
{{ item.author }}

数据更新时间：{{ monograph.updateTime }}

作者：
{{ item.author }}

数据更新时间：{{ sciAawards.updateTime }}

作者：
{{ item.author }}

数据更新时间：{{ conferencePapers.updateTime }}

作者：
{{ item.author }}

数据更新时间：{{ patent.updateTime }}

Johnson, Douglas其他文献

Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses

DOI：
10.1371/journal.pone.0047492
发表时间：
2012-10-16
期刊：
PLOS ONE
影响因子：
3.7
作者：
Chua, Brendon Y.;Johnson, Douglas;Jackson, David C.
通讯作者：
Jackson, David C.

Dermatologist and gastroenterologist awareness of the potential of immunosuppressants used to treat inflammatory bowel disease to cause non-melanoma skin cancer

DOI：
10.1111/j.1365-4632.2012.5612.x
发表时间：
2013-08-01
期刊：
INTERNATIONAL JOURNAL OF DERMATOLOGY
影响因子：
3.6
作者：
De Luca, Jacqueline F.;Severino, Richard;Johnson, Douglas
通讯作者：
Johnson, Douglas

IMpleMenting Effective infection prevention and control in ReSidential aged carE (IMMERSE): protocol for a multi-level mixed methods implementation study.

DOI：
10.1186/s12877-023-03766-9
发表时间：
2023-02-23
期刊：
BMC GERIATRICS
影响因子：
4.1
作者：
Tropea, Joanne;Peters, Sanne;Francis, Jill J.;Bennett, Noleen;Fetherstonhaugh, Deirdre;Buising, Kirsty;Lim, Lyn-li;Marshall, Caroline;Flynn, Madelaine;Murray, Michael;Yates, Paul;Aboltins, Craig;Johnson, Douglas;Kwong, Jason;Long, Karrie;McCahon, Judy;Lim, Wen K.
通讯作者：
Lim, Wen K.

Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.

DOI：
10.1111/apt.16952
发表时间：
2022-07
期刊：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
影响因子：
7.6
作者：
Fehily, Sasha R.;Al-Ani, Aysha H.;Abdelmalak, Jonathan;Rentch, Clarissa;Zhang, Eva;Denholm, Justin T.;Johnson, Douglas;Ng, Siew C.;Sharma, Vishal;Rubin, David T.;Gibson, Peter R.;Christensen, Britt
通讯作者：
Christensen, Britt

Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study.

DOI：
10.1016/j.lanwpc.2022.100533
发表时间：
2022-09
期刊：
LANCET REGIONAL HEALTH-WESTERN PACIFIC
影响因子：
7.1
作者：
Jenney, Adam;Chibo, Doris;Batty, Mitch;Druce, Julian;Melvin, Robert;Stewardson, Andrew;Dennison, Amanda;Symes, Sally;Kinsella, Paul;Tran, Thomas;Mackenzie, Charlene;Johnson, Douglas;Thevarajan, Irani;McGrath, Christian;Matlock, Amelia;Prestedge, Jacqueline;Gooey, Megan;Roney, Janine;Bobbitt, Joanne;Yallop, Sarah;Catton, Mike;Williamson, Deborah A.
通讯作者：
Williamson, Deborah A.